115% increase over prior year
ROCHESTER, N.Y., July 15 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that its backlog currently exceeds $20 million compared to $9.3 million at the same time a year ago, a greater than 100% increase. The company calculates backlog as the amount remaining to be recognized from active contracts and awards. Included in the backlog is approximately $11 million in 2008 project awards, and expansions to current studies, which compares to approximately $5.7 million for the same period in 2007.
"We are extremely pleased that our project backlog has exceeded $20 million for the first time in our history, this is a tremendous achievement for the company," said VirtualScopics' President and Chief Executive Officer, Jeff Markin. "Our growth in backlog coupled with a greater than 90% year over year increase in new contract awards are the best indicators of the acceptance and demand in the marketplace for our services." He further added, "We are excited about the progress to date and are looking forward to continued momentum as we enter the second half of the year."
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit http://www.virtualscopics.com .
The statements contained in this press release that are not purely
historical are forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended, and are intended to be covered by the
safe harbors created thereby. These forward-looking statements include, but
are not limited to, statements regarding the backlog and new customer
awards in 2008 and/or statements preceded by, followed by or that include
the words "believes," "could," "expects," "anticipates," "estimates,"
"intends," "plans," "projects," "seeks," or similar expressions.
Forward-looking statements deal with the Company's current plans,
intentions, beliefs and expectations. Investors are cautioned that all
forward-looking statements involve risks and uncertainties that could cause
actual results to differ materially from those in the forward-looking
statements. Many of these risks and uncertainties are discussed in the
Company's Annual Report on Form 10-KSB for the fiscal year ended December
31, 2007 filed with the Securities and Exchange Commission (the "SEC"), and
in any subsequent reports filed with the SEC, all of which are available at
the SEC's website at http://www.sec.gov . These include without limitation: the
risk of cancellation or delay of customer contracts or specifically as it
relates to awards of contracts currently under negotiation, the risk that
they may not get signed. Other risks include the company's dependence on
its largest customers and risks of contract performance. All
forward-looking statements speak only as of the date of this press release
and the Company undertakes no obligation to update such forward-looking
Investor Relations Contact: Company Contact:
BPC Financial Marketing Molly Henderson
John Baldissera Chief Business and Financial Officer
(800)368.1217 500 Linden Oaks
Rochester, New York 14625
|SOURCE VirtualScopics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved